The involvement of ferredoxin-NADP+ reductase in cyclic electron transport in chloroplasts.
The sites of action, in spinach thylakoid, of known inhibitors of electron transport at the reducing end of photosystem I have been more accurately located by parallel investigation of effects on three partial reactions: photo-reduction (from water) of added NADP+, photoreduction of added cytochrome c, and dark reduction of cyto-chrome c by added NADPH. Comparison with inhibitory effects on cyclic electron flow (registered by the slow phase of the electrochromic response during repetitive flash excitation) permitted assessment of the role of ferredoxin and ferredoxin-NADP+ reductase (ferredoxin: NADP+ oxidoreductase, EC 1.18.1.3) in the cyclic electron transport pathway around photosystem I. Disulfodisalicylidenepropane-1,1-diamine inhibited all the above partial reactions except the ferredoxin-dependent photoreduction of cytochrome C. thereby indicating its interference with the reductase or the complexation between reductase and ferredoxin. Studies with purified ferredoxin-NADP+ reductase established it as the sensitive component. Cyclic flow is also sensitive to the above inhibitor and thus presumably involves the reductase. Supporting evidence for this came from studies of inhibition by substituted maleimides, which are inhibitors of electron transfer through the isolated reductase; these also inhibited the slow phase of the electrochromic response and all partial reactions except the photoreduction of cytochrome c. In contrast, an antiserum against the reductase affected only reactions involving NADP. The conclusion is drawn that the pathway of cyclic electron transport includes both ferredoxin and ferredoxin-NADP+ reductase, but not the NADP-binding site on the reductase.
D002736:Chloroplasts / Q000187:drug effects / Q000201:enzymology*; D004579:Electron Transport; D005287:Ferredoxin-NADP Reductase / Q000037:antagonists & inhibitors* / Q000276:immunology; D005288:Ferredoxins / Q000378:metabolism; D007106:Immune Sera / Q000494:pharmacology; D008301:Maleimides / Q000494:pharmacology; D009247:NADH, NADPH Oxidoreductases / Q000037:antagonists & inhibitors*; D010788:Photosynthesis; D014105:Tosyl Compounds
D005288:Ferredoxins; D007106:Immune Sera; D008301:Maleimides; D014105:Tosyl Compounds; C032144:disulfodisalicylidenepropane-1,1-diamine; D005287:Ferredoxin-NADP Reductase; D009247:NADH, NADPH Oxidoreductases